MSH2 and invasive carcinoma: Interestingly, alterations in expression of MMR proteins MLH1 and MSH2 have been reported in a variable proportion of NSCLC ranging from 18%4 to 61%,5 but no studies have investigated the role of reduced protein expression in precursor lesions of NSCLC and very few have investigated their potential prognostic significance in invasive carcinomas.